“Superior Antiemetic Therapy for Optimal Patient Outcomes”.

Gritrox (Granisetron HCl) 1 mg Film Coated Tablet is a highly selective 5-HT3 receptor antagonist for the oral prevention of nausea and vomiting associated with chemotherapy, radiotherapy, surgery and other severe emetogenic conditions.

Indications:

• Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy (including high-dose cisplatin)
• Prevention of nausea and vomiting associated with radiation (total body irradiation and fractionated abdominal radiation)
• Postoperative and other severe or refractory nausea and vomiting unresponsive to standard antiemetics
• Other severe emetogenic conditions

Pharmaceutical Form:

Film-coated tablets: 1 mg

Dosage & Administration:

• 2 mg once daily (two 1 mg tablets) up to 1 hour before chemotherapy, or
• 1 mg twice daily (first tablet up to 1 hour before chemotherapy, second tablet 12 hours later)

Radiation-induced nausea & vomiting:
2 mg once daily (two 1 mg tablets) within 1 hour of radiation

Other severe/refractory nausea & vomiting: 1 mg every 12 hours or 2 mg once daily.

Pack Size: 10’S